IQM Selected to Deliver Two Advanced Quantum Computers as Part of Euro-Q-Exa Hybrid System
The EuroHPC Joint Undertaking (EuroHPC JU) has signed a purchase agreement with IQM Quantum Computers (IQM), a global leader in designing, building, and selling superconducting quantum computers. Under the agreement, IQM will deliver two advanced Radiance quantum systems of 54 qubits and 150 qubits in the second half of 2025 and by the end of 2026, respectively.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241016041576/en/
IQM Quantum Computer (Photo: Business Wire)
The two distinct systems, featuring high-quality qubits and industry-leading fidelities will play a pivotal role in executing quantum algorithms across a range of application domains.
The systems will be integrated into the high-performance computing infrastructure at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences and Humanities in Germany and will be accessed by scientists, researchers and European end-users from industry across Europe allowing to utilize fully hybrid HPC-QC workflows developed as part of the Munich Quantum Software Stack (MQSS).
LRZ is one of currently six European sites to operate and further develop hybrid supercomputers, accelerated by quantum technologies for EuroHPC JU. Starting in spring 2025, this system will be made available to the European research community as a first step - a strategic opportunity that contributed to the EuroHPC JU selecting LRZ.
This early availability will help bridge the development and installation phases of the Euro-Q-Exa systems and its components, ensuring researchers can access quantum technology as soon as possible. The EuroHPC JU and its national co-investors are committed to positioning Europe as a pioneer in developing market-ready quantum hardware and software.
In the summer of 2024, LRZ and IQM launched Germany’s first hybrid HPC-quantum computer, equipped with a 20-qubit processor. This collaboration will further unlock new possibilities in quantum computing innovation.
“The contract for the acquisition of the European quantum system Euro-Q-Exa at the Leibniz Supercomputing Centre in Garching secures the Free State of Bavaria, a leading position in Europe. Thanks to the cooperation with the pioneering quantum startup IQM, we are helping to build the European infrastructure. Here in Bavaria, we will test and further develop the practical applications of quantum computing. It is crucial that we are involved when it comes to one of the most promising technologies of the future. 54 qubits doesn't sound like much, but it is the gateway to a whole new universe. In the future, researchers will be able to provide answers to previously unsolvable questions. I congratulate LRZ and IQM on their success in the Champions League of quantum computing,” said Markus Blume, Bavarian State Minister for Science and the Arts.
“Since our inception, we have proven not only our technical capabilities to deliver but also shown numerous advantages of integrating quantum computing with HPC resources,” said Dr. Jan Goetz, Co-CEO at IQM Quantum Computers. "The collaborative efforts across Europe to integrate quantum computing into HPC centres are remarkable and perfectly aligned with our technology strategy. As we continue to meet the accelerating needs of our customers globally, we are excited to deploy our advanced systems at LRZ, driving scientific breakthroughs, fostering R&D, and creating new opportunities for industrial innovation in Germany and across Europe.”
“We are very proud to be able to build the foundation of a European quantum ecosystem with Euro-Q-Exa. At the LRZ, quantum computing is being made available to users in order to gain new insights in research. The collaboration in Europe and with our partner IQM makes this step possible and allows us to continue working at the forefront of global quantum computing development,” said Prof. Dr Dieter Kranzlmüller, Chairman of the Board of Directors of the Leibniz Supercomputing Centre.
For more details on hybrid systems procured by EuroHPC JU see their latest press release: https://eurohpc-ju.europa.eu/signature-procurement-contract-eurohpc-quantum-computer-located-germany-2024-10-15_en
About the EuroHPC Joint Undertaking
EuroHPC-JU is a legal and financial entity established in 2018, which signed agreements with six data centres in Europe in June 2023 to host and operate EuroHPC-JU hybrid quantum computers. The aim is to establish different platforms for quantum computing and hybrid quantum architectures, and to make them available as soon as possible to end-users from all over Europe. The planned integration of quantum systems into classical HPC structures also requires dedicated research and development on a hybrid software stack that manages both HPC and quantum computing (QC) workloads. During the integration work, all sites will work closely with European standardisation bodies. https://eurohpc-ju.europa.eu/index_en
About IQM Quantum Computers:
IQM is a global leader in designing, building, and selling superconducting quantum computers. IQM provides both on-premises full-stack quantum computers and a cloud platform to access its computers anywhere in the world. IQM customers include the leading high-performance computing centres, research labs, universities and enterprises which have full access to IQM's software and hardware. IQM has over 280 employees with offices in Espoo, Madrid, Munich, Paris, Palo Alto, Singapore and Warsaw.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241016041576/en/
Contacts
Media:
Email: press@meetiqm.com
Mobile: +358504790845
www.meetiqm.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Feuc-word-edit.
officeapps.live.com%2Fwe%2Fwordeditorframe.aspx%3Fui%3Den-US%26rs%3Dfi-FI%26wopi
src%3Dhttps%253A%252F%252Fmeetiqm.sharepoint.com%252Fsites%252FBusDevPublicAffai
rs%252F_vti_bin%252Fwopi.ashx%252Ffiles%252F58ae32dd65074dc3989982ec21ac3a92%26w
denableroaming%3D1%26mscc%3D1%26hid%3D01BB51A1-A0D5-9000-E957-8F42BFE0E568.0%26u
ih%3Dsharepointcom%26wdlcid%3Den-US%26jsapi%3D1%26jsapiver%3Dv2%26corrid%3Dcd15d
282-01fe-e5e6-7c32-fcae0f352a0c%26usid%3Dcd15d282-01fe-e5e6-7c32-fcae0f352a0c%26
newsession%3D1%26sftc%3D1%26uihit%3Ddocaspx%26muv%3D1%26cac%3D1%26sams%3D1%26mtf
%3D1%26sfp%3D1%26sdp%3D1%26hch%3D1%26hwfh%3D1%26dchat%3D1%26sc%3D%257B%2522pmo%2
522%253A%2522https%253A%252F%252Fmeetiqm.sharepoint.com%2522%252C%2522pmshare%25
22%253Atrue%257D%26ctp%3DLeastProtected%26rct%3DNormal%26wdorigin%3DOther%26inst
antedit%3D1%26wopicomplete%3D1%26wdredirectionreason%3DUnified_SingleFlush&eshee
t=54136815&newsitemid=20241016041576&lan=en-US&anchor=www.meetiqm.com&index=4&md
5=b4cb25450f627129f5146ad8b6d0f026
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Receives Marketing Clearance for Lumipulse ® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 09:58:00 EEST | Press release
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause of disability and death. AD develops over many years, long before symptoms are evident, but the lack of accessible, minimally invasive diagnostics results in many patients remaining undiagnosed until the disease is well advanced, when few effective interventions remain. The Lumipulse G pT
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes17.5.2025 00:17:00 EEST | Press release
IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050
Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 16:00:00 EEST | Press release
Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy and accessibility to even more consumers. Amazon customers will now be able to discover and purchase Or
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 13:47:00 EEST | Press release
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 13:30:00 EEST | Press release
IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom